Sacro Iliac Joint Pain Clinical Trial
Official title:
A Sham, Controlled, Randomised Trial to Investigate the Effects of Radiofrequency Neurotomy Using Simplicity III® on Patients With Sacroiliac Joint Pain.
The purpose of the study is to investigate if a technique called Simplicity III®
Radiofrequency Neurotomy is effective in improving the management of sacroiliac joint pain.
Currently there are a variety of treatments for managing this pain but there is still some
doubt as to which treatments are the most effective. Simplicity III® is one such treatment
for sacroiliac joint pain and has been used in the NHS for many years. It uses electrical
current to generate heat around the tip of the needle placed close to the nerves that supply
the sacro-iliac joint. This heat ablates the specific nerves supplying the joint and
improves pain.
The traditional method used to treat this type of pain uses multiple injections to target
the nerves supplying the joint. This method is however both time consuming and the results
are variable depending upon the number of injections. Therefore a new electrode, called the
Simplicity III®, was developed to allow the treatment to be undertaken using fewer
injections. Although this treatment has received formal approval, undergone conformity
assessment and is available in certain specialist NHS centres for clinical use, there is
presently limited evidence with regards to its clinical efficacy. We wish to test the
effectiveness of this new device in treating sacroiliac joint pain. The best way to prove
the clinical effectiveness is to compare Simplicity III® against an identical procedure
where the electrode is not switched on and neither the patient nor the doctor is aware
whether it was switched on. Once pain has been assessed at 3 months, those patients not
receiving active treatment and remaining in pain will be offered the active treatment.
| Status | Recruiting |
| Enrollment | 30 |
| Est. completion date | |
| Est. primary completion date | December 2013 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years to 80 Years |
| Eligibility |
Inclusion Criteria: 1. Written, informed consent 2. Age: 18 - 80 years old 3. Low back pain of more than 6 months duration with a minimum pain intensity of greater than 5 out of 10 on an 11-point numerical rating scale in the 7 days preceding study entry. 4. Subjects must achieve greater than 80% reduction in pain following each diagnostic, intra-articular block. Subjects must undergo 2 blocks in total prior to randomisation. 5. Female subjects of potential childbearing age must be using adequate contraception (i.e. using oral or intramuscular contraception or an IUCD) and must have a negative urine test. 6. No vulnerable patient groups shall be recruited into this study Exclusion Criteria: 1. Subjects who do not fulfill inclusion criteria 2. Subjects who have previously been treated by any sacroiliac joint radiofrequency neurotomy 3. Subjects who are breastfeeding 4. Contraindications to local anaesthetics and radiofrequency neurotomy as listed in their respective summary of product characteristics 5. Subjects with documented or suspected alcohol or drug abuse, or who are suspected of having an addictive personality 6. Subjects to whom any of the following apply: Major trauma to the lumbar spine in the six months preceding study entry. Infection in the lumbar spine in the six months preceding study entry 7. Subjects' known to have a condition that, in the investigator's judgment precludes entry into the study. 8. Subjects with a significant psychiatric disorder (including depression) or subjects receiving anti-psychotic medication. 9. Subjects who have received an investigational drug or have used an investigational device in the 30 days preceding study entry. 10. Subjects unable to comply with the study assessments or unable to complete the questionnaires. |
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment
| Country | Name | City | State |
|---|---|---|---|
| United Kingdom | Barts Health NHS Trust | London |
| Lead Sponsor | Collaborator |
|---|---|
| Barts & The London NHS Trust |
United Kingdom,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Pain Intensity | 3 months | Yes | |
| Secondary | Pain Intensity | 6 months | Yes | |
| Secondary | Quality of pain | Short Form Mcgill Pain Questionnaire | 3 and 6 months | No |
| Secondary | Health related Quality of life | Short form health survey | 3 and 6 months | No |
| Secondary | Anxiety and Depression | Hospital and Depression Scale | 3 and 6 months | No |
| Secondary | Functional Disability | Oswestry Low Back Pain Disability Questionnaire | 3 and 6 months | No |
| Secondary | Health related quality of life and quality-adjusted life years | Euro Quol EQ-5D scale | 3 and 6 months | No |
| Secondary | Portion of patients randomised to sham requiring rescue therapy with RFN | 3 and 6 months | No |